ACTRN12617000608369已完成未知
The Sweet Spot: A randomised controlled trial comparing five levels of support for an anxiety and depression course plus usual care, to usual care alone
St Vincent's Hospital Sydney0 个研究点目标入组 713 人开始时间: 2017年4月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 713
研究概览
简要总结
In progress. Will update when available.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •People aged over 18 years old who score 10-24 on the PHQ-9 and/or >9 on the GAD-7. Participants must be prepared to provide their name, age, gender, level of education, phone number and information on health service utilisation. Participants are required to have English language skills equivalent to a School Certificate level, access to a phone and a computer with a printer, and must provide electronic informed consent.
排除标准
- •People with a self-reported diagnosis of schizophrenia, bipolar disorder, substance dependence and/or taking benzodiazepines on a daily basis; and/or a score of < 9 on the PHQ-9 or GAD-7; of 2 or 3 on Item 9 of the PHQ-9 and/or >24 on the PHQ-9 (i.e. sub-threshold anxiety or depression; very severe depression or frequent suicidal ideation).
研究者
相似试验
尚未招募
不适用
Prevention of fallingFallingFunctional decline ElderlyPreventionNL-OMON26703one496
已完成
不适用
While you're waiting - A waiting room-based, tablet-delivered program of educational videos designed to increase motivation to change lifestyle behaviours and improve clinic experienceCardiovascular - Coronary heart diseaseCardiovascular diseaseACTRN12618001725257niversity of Sydney330
Unknown
不适用
Trial for the Treatment of Pelvic and Back Pain in PregnancyPelvic Girdle PainSymphysio Pubic DysfunctionNCT00830934University College Cork226
已完成
2 期
Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart FailureIschemic CardiomyopathyNCT02501811The University of Texas Health Science Center, Houston125
已完成
1 期
A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe OsteoarthritisOsteoarthritisNCT02188771ProCore Ltd.11